FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

786089001: Product containing only Varicella-zoster virus antibody in parenteral dose form (medicinal product form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3770789019 Varicella-zoster virus antibody only product in parenteral dose form en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
3770790011 Product containing only Varicella-zoster virus antibody in parenteral dose form (medicinal product form) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core


5 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Varicella-zoster virus antibody only product in parenteral dose form Count of base of active ingredient un false Inferred relationship Some
Varicella-zoster virus antibody only product in parenteral dose form est un(e) (attribut) Varicella-zoster virus antibody only product true Inferred relationship Some
Varicella-zoster virus antibody only product in parenteral dose form a une forme pharmaceutique (attribut) forme pharmaceutique pour usage parentéral (forme pharmaceutique) true Inferred relationship Some
Varicella-zoster virus antibody only product in parenteral dose form est un(e) (attribut) Varicella-zoster virus antibody-containing product in parenteral dose form true Inferred relationship Some
Varicella-zoster virus antibody only product in parenteral dose form a pour principe actif (attribut) Varicella immunoglobulin true Inferred relationship Some 1
Varicella-zoster virus antibody only product in parenteral dose form Plays role Passive immunity stimulant therapeutic role true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
poudre de 500 mg d'immunoglobuline contre le virus varicella-zoster pour solution injectable en flacon (médicament clinique) est un(e) (attribut) True Varicella-zoster virus antibody only product in parenteral dose form Inferred relationship Some
Varicella-zoster virus antibody 104 unit/mL solution for injection est un(e) (attribut) True Varicella-zoster virus antibody only product in parenteral dose form Inferred relationship Some
poudre de 250 mg d'immunoglobuline contre le virus varicella-zoster pour solution injectable en flacon (médicament clinique) est un(e) (attribut) True Varicella-zoster virus antibody only product in parenteral dose form Inferred relationship Some
VariZIG 125 international units powder and diluent for solution for injection Cangene Corporation (real clinical drug) est un(e) (attribut) True Varicella-zoster virus antibody only product in parenteral dose form Inferred relationship Some

This concept is not in any reference sets

Back to Start